Independent provider comparison
Updated September 27, 2026
A side-by-side look at total cost, medication format, care, commitment and the situations where each option makes more sense.
Embody’s GLP-1 website is joinem.co. GLP-1 Picks is an independent comparison site.
The short decision
We would start with Embody if you want a compounded injection and a clearly priced one-month option. Willow is worth considering if you specifically want to discuss a daily compounded tablet with a clinician, since Embody's current catalogue lists injections. Our preference for Embody in the injection case reflects its published $79 one-month semaglutide bundle. If your priority is an FDA-approved pill, neither company's compounded tablet or injection should be treated as that product.
Both providers pay us a commission through our links. Commissions do not set scores or the facts compared here. How we make money.
Our pick for a simple cash-pay injection plan
Medication, clinical review, coaching and shipping in one plan. Start with one month if you want a smaller initial commitment.
Semaglutide: $79 for one month, or $828 prepaid for a year ($69/month equivalent). Compounded treatment requires clinical approval and is not FDA approved.
Explore Embody's plans Read our Embody review
Choose Willow to discuss a tablet format
Willow offers compounded semaglutide and tirzepatide as injections and daily tablets, with online clinical support. Format is its clearest distinction in this pair.
Compounded tablets are not FDA-approved Wegovy or Foundayo pills. Ask the clinician about the specific preparation, evidence and dose price.
Explore Willow's options Read our Willow reviewSources: Embody catalogue and payment terms · Willow program and care details
Cost
First charge, renewal and commitment
Treatment
Medication, form and approval status
Care
Clinical review and ongoing support
Terms
Cancellation and material cautions
Side by side
Compare the price unit as well as the number. A medication-only price, prepaid monthly equivalent and complete recurring program are not the same thing.
| Feature | Embody | Willow |
|---|---|---|
| Why each one | Publishes a complete four-tier price ladder for both molecules, so the commitment behind every advertised rate is checkable rather than implied. | A compounded program with separate semaglutide and tirzepatide dissolving tablets, plus a combination tablet. The format choice may suit a reader who wants to discuss needle-free treatment with a clinician; it does not establish equivalence to an approved pill or injection. |
| Our Score | 7.3/10 | 7.5/10 |
| Headline Price | from $69/mo | from $299/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | People who want to compare Embody's published plan menu with its separate monthly promotion and will confirm the exact charge, term and refund rules before paying | Users who want comprehensive clinical support with a needle-free daily tablet option on both semaglutide and tirzepatide |
| Watch out for | Payments are normally non-refundable. If Embody's provider determines medical disqualification, its refund policy allows a refund for unused services after deducting services already provided. Cancellation otherwise stops future renewal. The twelve-month semaglutide plan commits $828 up front; cancellation requests must reach support at least 72 hours before the next billing date. | Compounded-only, no brand-name Wegovy or Zepbound through the platform |
| Ranking | #17 | #10 |
| Get started | Visit Embody | Visit Willow |
For Embody's one-month prices, prepaid totals and conflicting billing terms, read the Embody price and payment breakdown.
Trade-offs
Willow lists daily compounded semaglutide and tirzepatide tablets alongside injections. A tablet preference is a valid reason to ask about the service, but the preparation matters: compounded tablets are not FDA-approved brands and cannot inherit an injection's trial results. Discuss the evidence, dose, availability and total price with the prescribing clinician before selecting a format.
Sources: Willow program and care details
Embody's public catalogue lets you compare one month with longer prepaid terms. The semaglutide options are $79 for one month or $828 paid for twelve months, equivalent to $69 a month. The lower equivalent is a commitment, not a $69 monthly bill. Its separate promotional offer may carry different terms; confirm the charge and renewal shown during signup.
For an eligible patient who wants a compounded injection, that one-month option is our practical starting point. Clinical approval is required. Compounded medicines are not FDA approved, and paid plans are normally non-refundable; Embody publishes a limited exception for provider-determined medical disqualification. Compare the plan's fit before committing to a longer term.
Sources: Embody catalogue and payment terms · Embody cancellation and refund terms · FDA on compounded medicines
Keep narrowing the decision
Use the unresolved part of this choice, not a generic related article. These guides own the broader medication, coverage or complete-cost question.
More head-to-head comparisons involving Embody and Willow.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Embody legit and is Willow legit, with the verification evidence behind each answer.
